STRATEGIES FOR TREATING GOUT GOUT Dr. Sultan Al-Mogairen Assistant Professor & Consultant Rheumatology Division.

Slides:



Advertisements
Similar presentations
GOUT Disease caused by tissue deposition of Monosodium urate crystals as a result of supersatuaration of extra cellular fluid with MSU.
Advertisements

Little Rheumatology gems for GP Trainees HDR 7/12/10 Hayley Faries, ST1 Rheumatology.
Team Meeting Presentations
Copyright © 2015 Cengage Learning® Chapter 15 Urinary System Drugs.
1. Describe the pathogenesis of hyperuricemia and gout Goup C1 Group C1.
Heel pain in an adult male Hatem H Eleishi, MD Lecturer of Rheumatology, Cairo University June 2004.
ALLAH(SWT) HAVE ORDERED US TO BE NICE WITH PARENTS وَاعْبُدُواْ اللّهَ وَلاَ تُشْرِكُواْ بِهِ شَيْئًا وَبِالْوَالِدَيْنِ إِحْسَانًا Extracted from Chapter.
FREEDOM FROM RHEUMATOLOGICAL DISORDERS
SUA
GOUT AND PSEUDOGOUT ANDRES QUICENO, MD Rheumatology Division
{ Gout and Bursitis Asfand Baig.   Inflammatory arthritis associated with hyperuricaemia* and intra-articular sodium urate crystals Gout.
Prepared by : Tamara Odeh Diana Jawhari Supervised by : Dr. Ola Ayesh.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 74 Drug Therapy of Gout.
Arthritis New Zealand Gout Georgina Greville RN Arthritis Educator.
Gout.
Gout : Clinical review and trial design issues Joel Schiffenbauer FDA/DAAODP AAC/June 3, 2004.
 Gout is characterized by elevated uric acid concentrations in blood and urine due to variety of metabolic abnormalities that include overproduction.
DR. ABDULRAHMAN AL-AJLAN
Gout & hyperuricemia.
Gout: Its not all crystal clear Robert L. Wortmann, M.D. Department of Internal Medicine The University of Oklahoma College of Medicine, Tulsa.
Gout Dr. Wael H.Mansy, MD Assistant Professor College of Pharmacy King Saud University.
Familial metabolic disease Characterized by : Acute arthritis Uric stones in the kidneys Hyperuricemia.
GOUT. By Prof. Azza El- Medany Dr. Osama Yousf OBJECTIVES At the end of lectures students should : Define gout Describe outlines of treatment Describe.
Gout By Shravya & Helen. Gout is… An inflammatory arthritis associated with hyperuricaemia and intra-articular sodium urate crystals.
GOUT. OBJECTIVES At the end of lectures students should : Define gout Describe outlines of treatment Describe treatment of acute gouty arthritis Describe.
HYPERURICEMIA and GOUT PATHOGENESIS. HYPERURICEMIA Plasma/serum urate concentration >408 mol/L (6.8 mg/dL) Present in between 2.0 and 13.2% of ambulatory.
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
GOUT. Definition Heterogeneous group of diseases involving : An elevated serum urate concentration (hyperuricemia) Recurrent attacks of acute arthritis.
Gout extra Q’s. After giving Marilyn analgesia you arrange an ultrasound and guided aspiration of Marilyn's first metatarsophalangeal joint. The initial.
GOUT TREATMENT. Gout prevalence doubled over the last 20 yrs. Factors? - longevity - diuretic use - low dose ASA - obesity - end stage renal disease -
Clinical cases.
Investigations: Urine examination. Urine examination. Serum K. Serum K. Serum creatinine. Serum creatinine. Blood Sugar. Blood Sugar. Hb. Hb.
Gout Gouty Arthritis By Mike Parenteau.
Clinical Case #6 By Chen, chun-Yu (Kim) Chen, I -chun (Afra) Chen, I -chun (Afra)
Four Stages of Gout  Asymptomatic hyperuricemia Elevated levels of uric acid in the blood but no other symptoms Does not require treatment  Acute gout/Acute.
CHAPTER © 2012 The McGraw-Hill Companies, Inc. All rights reserved. 20 Nonopioid Analgesics, Nonsteroidal Antiinflammatories, and Antigout Drugs.
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
GOUT. Demographics Affects middle-aged to elderly men postmenopausal and elderly women (usually have OA and HPN causing mild renal insufficiency, and.
Agents Used to Treat Hyperuricemia and Gout
GOUT A metabolic disease in which tissue deposition of crystals of monosodium urate occurs from supersaturated extracellular fluids and results in one.
GOUT: DIAGNOSIS AND MANAGEMENT. Gout Metabolic disorder due to excessive accumulation of uric acid in tissues leading to acute and chronic arthritis and.
Gout Treatment Megan Chan, PGY-2 UHCMC Gout Acute gouty arthritis = monosodium urate crystals in synovial fluid leukocytes – Serum urate ≥ 6.8 =
Gout. The most common cause of inflammatory arthritis in US adults (3.9% of Americans; approx. 8.3 million people; ) Prevalence is greater in.
PA Days Presentation Brian K. Shrawder, PA-S LHU.
Dr. Müge Bıçakçıgil Kalaycı
StagesClinical Features (1)Asymptomatic hyperuricemiahigh uric acid level is present but without symptoms (2) Acute Gouty Arthritishigh uric acid level.
Gout -revisited Shrenik Shah. definition Monosodium urate (MSU) crystal deposition  episodic and later persistent joint inflammation and tophi All MSU.
GOUTY ARTHRITIS PRESENTED BY, JISMI MATHEW LINCY K OUSEPH MEENUPRIYA OONNANAL SMITHA V CHACKO VINEETHA MARY MATHEW.
Gout and Pseudogout dr. MUH. ARDI MUNIR, M.Kes., Sp.OT., M.H., FICS.
Colchicine: Colchicine: Effective & specific gout Rx, but less favored than NSAIDs because of slow onset of action & high incidence of side effects. Effective.
Righteousness Mahmoud Ghazi Kassem Instructor:Dr.Hajredin Hoxha Qatar University
Gout Pharmacotherapies Joseph Kitzmiller MD PhD FCP 5086 Graves Hall Assistant Professor – Biological Chemistry & Pharmacology
GERIATRICS Dr. Meg-angela Christi Amores. Musculoskeletal Disorders in the Elderly  Osteoarthritis  Rheumatoid Arthritis  Gout (Gouty arthritis) 
© Copyright Annals of Internal Medicine, 2016 Ann Int Med. 165 (1): ITC1-1. In the Clinic Gout.
Gout Ashley Guzman Primary Care I: Acute and Chronic Health Problems
GOUT GOUT.
Crystalopathies Joanna Zalewska.
Gout Asad Khan Consultant Rheumatologist
Gout.
Drug Therapy of Gout 1.
Gout and Hyperuricaemia
Antiuricaemic drugs Dr A.W Olusanya.
Mr. Smith, 51, came to the family doctor because of severe pain in his left knee. The patient gave the pain began suddenly at 2 am, woke him from his.
Lecture 9 Musculoskeletal Disorders Gout
Gout By: Patience Alley, Albert Watson, and Hunter Kimball.
Gout and Hyperuricaemia
Gout Scott Smith PGY-1 1/11/2018.
TREATMENT OF THE ACUTE GOUT ATTACK:
Presentation transcript:

STRATEGIES FOR TREATING GOUT GOUT Dr. Sultan Al-Mogairen Assistant Professor & Consultant Rheumatology Division

Gout is clinical syndrome with monosodium urate deposition characterized biochemically by extracellular urate supersaturation and clinically manifested by arthritis, tophi and uric A nephrolithiasis. Gout continued to be a healthy problem despite the availability of effective therapy.

Epidemiology In the West, the most frequent microcrystalline arthritis affect approximately 0.5 to 2.8 of adult men and 0.2 to 0.6% of adult women. The highest incidence of Gout occurs between 30 & 45 yrs of age in men and between 55 & 70 yrs of age in women. Prevalence of Gout increased in countries with a high standard changing in diet, lifestyle, increased use of thiazid diuretics and Aspirin. A review in Saudi Arabia, a population with rare alcohol consumption revealed prevalence of HPU 8.42% and no cases of Gout.

CLINICAL FEATURES ♦ More in male and in elderly ♦More equal gender distribution ♦About 80% of initial attack are monoarticular. ♦Polyarticular first attack are more common in elderly women and in patients with Gout accompanying myeloproliferative disorder or the use of cyclosporin. ♦Common sites include instep, ankle, heel, knee, elbow (olecranon bursa) wrist & finger ♦Rare sites: shoulders, sternoclav, spine, sacroiliac and hips. There is an association with the following: -DM, hyperlipidemia, obesity, HTN, renal impairment, diuretic, and ethanol consumption.

MANAGEMENT Aims of Therapy 1.Anti-inflammatory 2.Anti-hyperuricemia 3.Prophylactic 4.Nutritional strategies 5.Avoid ethanol consumption and drugs inducing HPU 6.Prevention and reversal of morbid consequences of HPT, hyperlipid

ANTI-INFLAMMATORY NSAID, Colchicine, CST ♦Do not reverse HPU or urate deposition. ♦Often reverse pain and inflammation and disability within several days rather than several weeks as in untreated patients. ♦Best response if started in 1 st few hrs and if patient well educated give instruction for Tt with 1 st twinge to be terminated in 1 to 3 days or colchicine 0.6 mg/hr till relief or total dose 6 mg or S/E, or Indomethacin 50 mg x 3 & other NSAID alternative routes PR (NSAID).

Regarding NSAIDS, no clear advantages of one over another. NSAIDColchicine Effect: More predictableUnpredictable and when started after 1 st 24 hr, decreased thera- peutic effect Generally, better toleratedNarrow benefit to toxicity ratio if normal kid (abdp.) Onset: 1 hr.Slow 12 hrs. CostCheaper

Once anti-HPU drugs has been initiated, it should not be interrupted during acute attacks. CST after securing Dx & r/o infection if: 1.Co-existing medical illness contraindicating 1 st line (NSAID & Colchicine), or 2.Due to intolerance to them, use steroid IV, IM or IA according to number of joints involved. 3.Precaution for IA inj if patient has skin infection or on anticoagulant. However, the effect of CST are inconsistent and rebound attacks after Tt D/C are frequently seen.

Potential drawbacks of ACTH: 1.Depends on response of Δ and might be suboptimal if on steroid previously. 2.Failure to deliver precise dose. 3.Increased release of Androgen and mineralo cort.

PROPHYLAXIS FOR ACUTE ATTACKS DURING INITIATION OF ANTI-HPU DRUGS Increased urinary Ur A excreted early in the course of uricosuric Tt can promote (urinary stone formation). In addition, acute fall in S. urate conc often precipitate (Acute Gouty Arthritis). Mech: Uncertain, but probably with decreased S. Ur A PMNs more efficient in phagocytosis.

Risks of relapse can be minimized by long- term use of: 1.Colchicine or 2.NSAID Colchicine induced neuromyopathies and NSAID induced PUD and Rend imp. by D/C drugs after persistent normouricemia.

Others said that pot toxicity of prolonged use of Colchicine (neuropathies, myelotoxicity) and the fact that the only minority (10 to 15%) of patients develop flare-up of Gouty Arthritis. After initiation of Allup. or uricosuric Tt, instead, many clinicians advocate the temporary use of supplemental NSAID or Colchicine to control these attacks.

ANTIHYPERURICEMIA DRUGS Goals: To reduce and maintain S. urate not just to within normal range but to the mid to lower half of normal range (6.8 mg/dL = 404 mmol/L) below range of which S. urate saturate the extracellular fluid (6.8 mg/dL= half of normal range (6.8 mg/dL = 404 mmol/L) below range of which S. urate saturate the extracellular fluid (6.8 mg/dL= 404 mmol/L). 404 mmol/L). This will prevent the gouty attack and promote resorption of tophaceous deposits.

In the absence of clear indication for Tt with Allup, some Rheumatologist recommend uricosuric because it is safe and do not influence purine and pyramidine metabolism.

DIET A severely purine restricted diet has traditionally been recommended for patient with Gout. Such a diet can reduce urinary Ur A excretion by 200 to 400 mg/day. However, mean S. urate conc decrease only about 1 mg/dL (59 µ mol/L).

Diet with restricted purine and protein contents are unpalatable and often neither practical nor effective in the management of HPU and Gout in patients with normal dietary habit. Furthermore, with availability of potent anti- HPU drugs, this dietary approach is rarely employed except in those with severe renal insufficiency or intolerance to pharmacologic therapy.

If dietary changes are employed to manage Gout, it may be preferable to recommend increasing dietary protein intake from low fat dairy product and to decrease the amount of red meat and fish ingestion.

THANK YOU

سورة الإسراء آية وَقَضَى رَبُّكَ أَلاَّ تَعْبُدُواْ إِلاَّ إِيَّاهُ وَبِالْوَالِدَيْنِ إِحْسَانًا إِمَّا يَبْلُغَنَّ عِندَكَ الْكِبَرَ أَحَدُهُمَا أَوْ كِلاَهُمَا فَلاَ تَقُل لَّهُمَآ أُفٍّ وَلاَ تَنْهَرْهُمَا وَقُل لَّهُمَا قَوْلاً كَرِيمًا وَقَضَى رَبُّكَ أَلاَّ تَعْبُدُواْ إِلاَّ إِيَّاهُ وَبِالْوَالِدَيْنِ إِحْسَانًا إِمَّا يَبْلُغَنَّ عِندَكَ الْكِبَرَ أَحَدُهُمَا أَوْ كِلاَهُمَا فَلاَ تَقُل لَّهُمَآ أُفٍّ وَلاَ تَنْهَرْهُمَا وَقُل لَّهُمَا قَوْلاً كَرِيمًا وَاخْفِضْ لَهُمَا جَنَاحَ الذُّلِّ مِنَ الرَّحْمَةِ وَقُل رَّبِّ ارْحَمْهُمَا كَمَا رَبَّيَانِي صَغِيرًا وَاخْفِضْ لَهُمَا جَنَاحَ الذُّلِّ مِنَ الرَّحْمَةِ وَقُل رَّبِّ ارْحَمْهُمَا كَمَا رَبَّيَانِي صَغِيرًا

التلطف في الكلام وعدم رفع الصوت. التلطف في الكلام وعدم رفع الصوت. إذا لم تسكن معهما تحرص على زيارتهما على الأقل ثلاث مرات في الأسبوع. إذا لم تسكن معهما تحرص على زيارتهما على الأقل ثلاث مرات في الأسبوع. الحرص على مشاعر هما ونفسيتهما. الحرص على مشاعر هما ونفسيتهما. تلبية حاجاتهما المالية بطيب نفس. تلبية حاجاتهما المالية بطيب نفس. لا يشعران بحرج ولا تردد في طلب ما يحتاجانه منك. لا يشعران بحرج ولا تردد في طلب ما يحتاجانه منك. الحرص على توفير وسائل الإتصال من جوال وسائق وسيارة. الحرص على توفير وسائل الإتصال من جوال وسائق وسيارة. إهدائهما هدية سنوية. إهدائهما هدية سنوية. متابعة وضعهما الصحي ومراجعتما للمستشفى. متابعة وضعهما الصحي ومراجعتما للمستشفى. ترويحهما خارج البيت ولو مرة في الشهر وتلبية حاجاتهما في السفر صيفا. ترويحهما خارج البيت ولو مرة في الشهر وتلبية حاجاتهما في السفر صيفا. الصدقة عنهما. الصدقة عنهما. درجة النجاح ( 7/10 ) Passing Mark